NEUMENTUM
Neumentum neurology specialty pharmaceutical company that develops and commercializes novel non-opioid pain products. At Neumentum, we are dedicated to developing safe, effective treatment options that address unmet needs in the management of pain, without the potential risks of misuse, addiction, or life-threatening side effects that may be found with opioid products. Neumentum has global rights to five novel non-opioid pain products, the most advanced of which are two phase 3-ready injectable products under development for acute postsurgical pain.
NEUMENTUM
Social Links:
Industry:
Biotechnology Health Care Life Science Pharmaceutical Therapeutics
Founded:
2017-03-28
Address:
Morristown, New Jersey, United States
Country:
United States
Website Url:
http://www.neumentum.com
Total Employee:
1+
Status:
Active
Contact:
9082396142
Email Addresses:
[email protected]
Total Funding:
24.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
AngelMD
AngelMD investment in Venture Round - Neumentum
Evolution VC Partners
Evolution VC Partners investment in Series A - Neumentum
Brookline Capital Markets
Brookline Capital Markets investment in Series A - Neumentum
Official Site Inspections
http://www.neumentum.com Semrush global rank: 9.71 M Semrush visits lastest month: 114
- Host name: server119-4.web-hosting.com
- IP address: 198.54.116.108
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Neumentum"
Better Options for Less Pain | Neumentum, Inc.
Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company.See details»
About Our Company | Neumentum, Inc.
Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company with 4 novel non-opioid products in development to treat pain, both in the U.S. and around the world.See details»
Leadership - Neumentum, Inc.
Our team is dedicated to building a leading non-opioid analgesic and neurology specialty pharmaceutical company. Dr. Joseph V. Pergolizzi, Jr., MD is an internationally recognized thought leader in internal, perioperative and pain …See details»
Neumentum, Inc. - LinkedIn
Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company with 4 novel non-opioid products in development to treat pain, both in the...See details»
Neumentum - Crunchbase Company Profile & Funding
Neumentum neurology specialty pharmaceutical company that develops and commercializes novel non-opioid pain products. At Neumentum, we are dedicated to developing safe, effective …See details»
Neumentum - Org Chart, Teams, Culture & Jobs - The Org
View Neumentum's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Neumentum Announces Initiation of Phase 3 Program Evaluating …
Jan 25, 2023 · NTM-001 is an Investigational, Alcohol-Free, Stable Formulation of Ketorolac in a Pre-Mixed Bag for 24h Continuous Infusion. NTM-001 has the Potential to Deliver Opioid …See details»
Neumentum Company Profile 2024: Valuation, Funding
Developer of a pharmaceutical platform intended to offer non-opioid pain therapeutics to patients.See details»
Neumentum - Products, Competitors, Financials, Employees, …
Neumentum is a pharmaceutical company focused on developing non-opioid analgesics and neurology specialty products. Its main offerings include novel non-opioid medications designed …See details»
Investors - Neumentum, Inc.
Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company, and transforming how pain is treated–without opioids. The Company …See details»
Neumentum - VentureRadar
Website: http://www.neumentum.com/ Develops non-opioid analgesic and neurology specialty pharmaceuticals, aiming to provide safe, effective pain management without risks of abuse, …See details»
Neumentum Company Profile - Office Locations, Competitors
Neumentum is a pain and neurology specialty pharmaceutical company that develops and commercializes novel non-opioid pain products.See details»
Neumentum and NEMA Research Inc. Named to Short-List of …
MORRISTOWN, N.J., Sept. 20, 2021 (GLOBE NEWSWIRE) -- The Citeline Awards, sponsored by Informa Pharma Intelligence, today announced that Neumentum Inc. and NEMA Research, …See details»
NEUMENTUM INC. Company Profile | Morristown, NJ
Find company research, competitor information, contact details & financial data for NEUMENTUM INC. of Morristown, NJ. Get the latest business insights from Dun & Bradstreet.See details»
Neumentum - Overview, News & Similar companies | ZoomInfo.com
Neumentum contact info: Phone number: (917) 865-0232 Website: www.neumentum.com What does Neumentum do? Neumentum is dedicated to becoming a leading non-opioid analgesic …See details»
Neumentum Presents Latest Data on NTM-006, a Novel
Aug 9, 2021 · Neumentum’s NTM-006 is a non-opioid, non-NSAID, non-gabapentinoid proprietary chemical entity (NCE), with a novel mechanism of action, with demonstrated analgesic activity …See details»
Neumentum Phase I Study Confirms Its Non-Opioid in …
Jan 7, 2019 · NTM-001 is Neumentum's lead product candidate: a novel, alcohol-free formulation of the powerful non-steroidal anti-inflammatory drug (NSAID) ketorolac in a pre-mixed bag …See details»
Neumentum Announces Initiation of Phase 3 Program Evaluating …
SUMMIT, NJ, January 25, 2023 – Neumentum, a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced the initiation of its …See details»
Neumentum and NEMA Research Inc. Named to Short-List of …
(Morristown, NJ – September 20, 2021) – The Citeline Awards, sponsored by Informa Pharma Intelligence, today announced that Neumentum Inc. and NEMA Research, Inc., have been …See details»
Neumentum Presents Latest Data on NTM-006, a Novel Non …
MORRISTOWN, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – …See details»